VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

10812	Companies
234244	Keywords
163039	Articles
125257	Press releases

Home
Companies
VALNEVA

BRIEF

published on 12/04/2024 at 07:05, 1 year 8 months ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
BRIEF

published on 12/04/2024 at 07:05, 1 year 8 months ago

Valneva publie ses résultats sur l'impact du chikungunya dans le British Medical Journal

Changement Climatique Chikungunya Impact Sur La Santé Fardeau Économique Étude Mondiale
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year 8 months ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year 8 months ago

Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya
Valneva SE annonce la publication d’un article sur l’impact sanitaire et économique mondial du chikungunya dans le British Medical Journal, mettant en lumière son lourd fardeau et ses coûts importants

Valneva SE Chikungunya British Medical Journal Impact Sanitaire Coûts Économiques
BRIEF

published on 11/26/2024 at 17:50, 1 year 8 months ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
BRIEF

published on 11/26/2024 at 17:50, 1 year 8 months ago

Valneva demande l'approbation de la FDA pour l'extension de son vaccin contre le chikungunya

Valneva Adolescents Vaccin Contre Le Chikungunya Demande Auprès De La FDA Persistance Des Anticorps
PRESS RELEASE

published on 11/26/2024 at 17:45, 1 year 8 months ago

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data

FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF

published on 10/10/2024 at 07:05, 1 year 9 months ago

Valneva présente ses perspectives lors d'une journée investisseurs à New York

Croissance Investisseurs Valneva Vaccins Lyme
BRIEF

published on 10/10/2024 at 07:05, 1 year 9 months ago

Valneva presents its outlook at an investor day in New York

Investors Growth Valneva Vaccines Lyme
PRESS RELEASE

published on 10/10/2024 at 07:00, 1 year 9 months ago

Valneva organise une journée investisseurs aujourd’hui à New York
Valneva organise une journée investisseurs à New York pour présenter ses activités vaccinales et stratégie de création de valeur. Des présentations sur leurs principaux projets de R&D seront diffusées en direct à 16h00 CET

R&D Valneva Vaccins Journée Investisseurs Création De Valeur

Accesswire

Published on 08/08/2026 at 00:00, 21 hours 46 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 22 hours 31 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 22 hours 46 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 23 hours 16 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 23 hours 31 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/08/2026 at 16:25, 5 hours 20 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 22 hours 25 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 2 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 2 hours ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 3 hours ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request

Les Echos

Published on 08/07/2026 at 18:54, 1 day 2 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 2 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 3 hours ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 3 hours ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 3 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE